Clinical Trial Update: Effects of Ocrevus in Relapsing Multiple Sclerosis [Phase 4]

View source ↗

Summary

This clinical trial update notes the Phase 4 study of Ocrevus (ocrelizumab) in relapsing-remitting multiple sclerosis, with status listed as active and not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Ocrevus (ocrelizumab)

Snippet

Sponsor: Georgia State University | Conditions: Relapsing Multiple Sclerosis | Phase 4 | Status: ACTIVE_NOT_RECRUITING